Newbridge Financial Services Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-65
| Closed | -$3.29K | – | 1131 |
|
|
2023
Q3 | $3.29K | Hold |
65
| – | – | ﹤0.01% | 1015 |
|
|
2023
Q2 | $3.04K | Hold |
65
| – | – | ﹤0.01% | 1086 |
|
|
2023
Q1 | $2.49K | Hold |
65
| – | – | ﹤0.01% | 1169 |
|
|
2022
Q4 | $3.56K | Hold |
65
| – | – | ﹤0.01% | 1125 |
|
|
2022
Q3 | $2K | Hold |
65
| – | – | ﹤0.01% | 1171 |
|
|
2022
Q2 | $1K | Hold |
65
| – | – | ﹤0.01% | 1246 |
|
|
2022
Q1 | $1K | Hold |
65
| – | – | ﹤0.01% | 1354 |
|
|
2021
Q4 | $1K | Hold |
65
| – | – | ﹤0.01% | 1297 |
|
|
2021
Q3 | $1K | Hold |
65
| – | – | ﹤0.01% | 1215 |
|
|
2021
Q2 | $2K | Hold |
65
| – | – | ﹤0.01% | 1252 |
|
|
2021
Q1 | $2K | Buy |
+65
| New | +$2K | ﹤0.01% | 1151 |
|